查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945805

臨床試驗設備及支援解決方案市場－全球產業規模、佔有率、趨勢、機會及預測（依產品、階段、地區及競爭格局分類，2021-2031年）

Clinical Trial Equipment & Ancillary Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Sourcing, Supply/Logistics, Service, Others), By Phase, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球臨床試驗設備及相關解決方案市場預計將從 2025 年的 40.5 億美元成長到 2031 年的 65.2 億美元，複合年成長率為 8.26%。

此領域涵蓋關鍵醫療設備、低溫運輸儲存基礎設施以及合規高效進行研究所需的物流服務。推動這一領域擴張的主要因素是全球臨床研究數量的成長以及研究通訊協定日益複雜，這需要專業的供應鏈管理。藥物開發平臺的活躍度活性化也印證了這一上升趨勢。例如，英國製藥工業協會 (ABPI) 報告稱，到 2024 年，英國啟動的新臨床試驗數量將比上一年增加 35.7%。這些因素凸顯了對可靠的設備採購和管理策略日益成長的需求，以促進藥物研發的加速發展。

市場概覽
預測期 2027-2031
市場規模：2025年 40.5億美元
市場規模：2031年 65.2億美元
複合年成長率：2026-2031年 8.26%
成長最快的細分市場 第三階段
最大的市場 北美洲

然而，這種積極勢頭面臨嚴峻挑戰，因為跨境引進設備需要滿足複雜的監管合規要求。管理全球各地不同的設備校準和進口標準往往會造成嚴重的物流瓶頸，導致研究啟動延遲和營運成本增加。因此，這些嚴格的監管障礙可能會阻礙輔助解決方案供應商順利拓展全球業務，從而影響其為跨國臨床試驗中心提供支援。

市場促進因素

藥品和生技製藥研發成本的不斷攀升是推動臨床試驗設備及輔助解決方案市場發展的主要動力。隨著製藥公司投入大量研發新治療方法，對專用醫療設備和物流基礎設施的投資也同步成長。這筆資金的湧入確保了試驗中心擁有必要的精密設備和儲存能力，以保障研究的完整性。例如，歐洲製藥工業協會聯合會（EFPIA）在2024年11月估計，歐洲以研發為基礎的製藥業當年在研發方面的投資約為550億歐元。這筆巨額資金直接用於輔助用品的採購，並確保複雜的生物樣本和臨床實驗藥品得到嚴格遵守安全標準的管理。

此外，全球臨床試驗數量的不斷成長推動了對可擴展支援解決方案和設備管理服務的需求。隨著平行研究的日益增多，穩健的供應鏈對於防止瓶頸並確保所有研究中心（無論其位於何處）都能及時獲得所需材料至關重要。 2025年4月，美國國立衛生研究院 (NIH) 宣布，截至2024年，在ClinicalTrials.gov網站上註冊的研究數量累計已超過50萬項。這一成長已超越了傳統的西方中心，涵蓋了眾多地區，因此需要針對每個地區制定相應的物流策略。歐洲生物技術雜誌2025年的報告指出，中國臨床試驗註冊中心在2024年記錄了約4900項臨床試驗，這凸顯了支持廣泛的國際研究活動對設備解決方案日益成長的需求。

市場挑戰

全球臨床試驗設備及輔助解決方案市場面臨的一大障礙是跨境設備部署所需的複雜監管合規要求。隨著臨床試驗擴大跨越多個國家以覆蓋不同的患者群體，供應商不得不應對設備進口和校準方面國際標準的碎片化。這種監管複雜性造成了嚴重的物流瓶頸，常常導致關鍵醫療設備和輔助用品的清關延誤，或需要獲得特定地區的認證才能在研究中心合法使用。

這些延誤直接影響研究進度的效率，並限制了市場在全球快速擴張的潛力。當輔助解決方案未能順利實施時，研究啟動將被推遲，這給依賴嚴格時間表的製藥申辦者造成了巨大的營運阻力。近期行業數據也印證了這項影響。根據臨床研究機構協會 (SCRS) 預測，到 2024 年，全球 35% 的臨床臨床實驗中心將把研究啟動流程列為一項主要的營運挑戰。這項統計數據凸顯了物流和監管方面的障礙（例如合規設備採購方面的障礙）如何顯著延遲研究啟動，從而限制了整個輔助解決方案市場的成長和流動性。

市場趨勢

隨著申辦方擴大利用遠端監測工具來提高患者參與度和保留率，分散式臨床試驗 (DCT) 設備的快速普及正在重塑市場格局。這一趨勢推動了以患者為中心的輔助解決方案（例如穿戴式感測器和家庭健康套件）需求的激增，這些解決方案能夠在傳統醫療機構之外收集數據。此模式在涵蓋代表性不足人群方面的有效性是其主要促進因素。例如，塔夫茨藥物研發研究中心 (Tufts Center for the Study of Drug Development) 於 2025 年 1 月報告稱，分散式試驗中亞裔參與者的比例已增至 20.9%，與傳統醫療機構研究中的 14.2% 相比，這是一個顯著的進步。因此，供應商正在轉型，提供輕鬆的遠端設備，以支援這些以多元化為重點的招募策略。

同時，在全產業積極推動永續性目標的推動下，環保且可重複使用的包裝解決方案備受關注。相關人員正迅速以循環物流模式取代一次性保溫包裝，以減少碳足跡並最大限度地減少臨床供應鏈中的廢棄物。這種營運模式的轉變也體現在主要低溫運輸供應商的策略中，他們正在擴大可重複使用資產的規模，以最大限度地提高庫存利用率。根據 Envirotainer 公司 2025 年 4 月發布的《永續發展報告》，該公司 75% 的貨物運輸採用單程租賃方式，其中 71% 的貨櫃透過訂單退回，從而避免空箱運輸。這項轉變凸顯了一種永久性的結構性變化，即環境因素日益成為採購決策中配套運輸解決方案的主要驅動力。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球臨床試驗設備及支援解決方案市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（採購（購買/租賃）、供應/物流、服務、其他）
    • 依階段（第一階段、第二階段、第三階段、第四階段）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美臨床試驗設備及配套解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲臨床試驗設備及配套解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區臨床試驗設備及配套解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲臨床試驗設備及配套解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲臨床試驗設備及配套解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球臨床試驗設備及輔助解決方案市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Ancillare, LP
  • Imperial Clinical Research Services Inc
  • Woodley Equipment Company Ltd
  • Thermo Fisher Scientific Inc
  • PAREXEL International Corp
  • Emsere
  • Quipment SAS
  • Marken Ltd.
  • Myonex
  • Yourway

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19548

The Global Clinical Trial Equipment and Ancillary Solutions Market for is projected to experience significant growth, increasing from USD 4.05 billion in 2025 to USD 6.52 billion by 2031, representing a CAGR of 8.26%. This sector includes critical medical devices, cold chain storage infrastructure, and logistics services necessary for conducting compliant and effective research studies. The primary drivers of this expansion are the rising global volume of clinical research and the growing complexity of study protocols, which require specialized supply chain management. This upward trend is demonstrated by heightened activity within pharmaceutical development pipelines; for instance, the Association of the British Pharmaceutical Industry reported a 35.7% increase in new clinical trial initiations in the UK in 2024 compared to the prior year. These factors emphasize the increasing need for reliable equipment procurement and management strategies to facilitate faster drug development.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.05 Billion
Market Size 2031USD 6.52 Billion
CAGR 2026-20318.26%
Fastest Growing SegmentPhase III
Largest MarketNorth America

However, this positive momentum faces substantial challenges due to the complex regulatory compliance required for deploying equipment across international borders. Managing diverse global standards for device calibration and importation often causes significant logistical bottlenecks that can delay study start times and escalate operational costs. Consequently, these strict regulatory barriers may hinder the smooth global expansion of ancillary solution providers as they endeavor to support multinational clinical trial sites.

Market Driver

Rising expenditures in pharmaceutical and biopharmaceutical research and development are serving as a major catalyst for the clinical trial equipment and ancillary solutions market. As drug developers dedicate significant capital to discovering novel therapies, there is a parallel increase in investment for specialized medical devices and logistical infrastructure. This financial influx ensures that trial sites possess the necessary precision instruments and storage capabilities to uphold study integrity. For example, the European Federation of Pharmaceutical Industries and Associations estimated in November 2024 that the research-based pharmaceutical industry in Europe invested approximately €55,000 million in R&D during that year. This massive capital injection directly supports the procurement of ancillary supplies, ensuring that complex biological samples and investigational products are managed in strict accordance with safety standards.

Additionally, the global proliferation of clinical trial volumes amplifies the demand for scalable ancillary solutions and equipment management services. As the frequency of concurrent studies rises, a robust supply chain is essential to prevent bottlenecks and ensure timely access to materials for all sites, regardless of location. The National Institutes of Health noted in April 2025 that the cumulative number of studies registered on ClinicalTrials.gov exceeded 500,000 in 2024. This expanding volume extends beyond traditional Western centers to include diverse regions requiring tailored logistical strategies; European Biotechnology reported in 2025 that the Chinese registry recorded approximately 4,900 clinical studies for 2024, highlighting the growing necessity for equipment solutions capable of supporting extensive international research operations.

Market Challenge

The primary obstacle hindering the Global Clinical Trial Equipment & Ancillary Solutions Market is the complex regulatory compliance required for deploying equipment across borders. As clinical trials increasingly span multiple countries to access diverse patient populations, vendors are forced to navigate a fragmented landscape of international standards regarding device importation and calibration. This regulatory complexity creates severe logistical bottlenecks, as essential medical devices and ancillary supplies frequently face prolonged detention at customs or require region-specific certification before they can be legally used at trial sites.

These delays directly compromise the efficiency of research timelines, limiting the market's potential for rapid global expansion. When ancillary solutions cannot be deployed seamlessly, trial initiation is postponed, causing substantial operational friction for pharmaceutical sponsors who depend on strict schedules. This impact is supported by recent industry data; according to the Society for Clinical Research Sites, in 2024, 35% of global investigative sites identified study start-up processes as a leading operational challenge. This statistic underscores how logistical and regulatory hurdles, such as those involved in compliant equipment procurement, critically stall the commencement of research, thereby restricting the overall growth and fluidity of the ancillary solutions market.

Market Trends

The market is being reshaped by the accelerated adoption of decentralized clinical trial (DCT) equipment, as sponsors increasingly utilize remote monitoring tools to improve patient inclusivity and retention. This trend is fueling a surge in demand for patient-centric ancillary solutions, such as wearable sensors and home-health kits, which facilitate data collection outside of traditional site settings. The effectiveness of this model in reaching underrepresented populations is a significant driver; for instance, the Tufts Center for the Study of Drug Development reported in January 2025 that decentralized trials increased Asian participant representation to 20.9%, compared to just 14.2% in traditional site-based studies. Consequently, equipment vendors are pivoting to provide lightweight, user-friendly remote devices that support these diversity-focused recruitment strategies.

Concurrently, there is a strong emphasis on eco-friendly and reusable packaging solutions, driven by aggressive industry-wide sustainability goals. Stakeholders are swiftly replacing single-use thermal packaging with circular logistics models to lower carbon footprints and minimize waste within the clinical supply chain. This operational shift is evident in the strategies of major cold chain providers who are expanding their pools of reusable assets to maximize inventory utility. Envirotainer's April 2025 sustainability report noted that 75% of its shipments utilized one-way leases, with 71% of these units returned via orders to avoid empty container movements. This transition highlights a permanent structural change wherein environmental stewardship increasingly dictates procurement decisions for ancillary shipping solutions.

Key Market Players

  • Ancillare, LP
  • Imperial Clinical Research Services Inc
  • Woodley Equipment Company Ltd
  • Thermo Fisher Scientific Inc
  • PAREXEL International Corp
  • Emsere
  • Quipment SAS
  • Marken Ltd.
  • Myonex
  • Yourway

Report Scope

In this report, the Global Clinical Trial Equipment & Ancillary Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Trial Equipment & Ancillary Solutions Market, By Product

  • Sourcing (Procurement, Rental)
  • Supply/Logistics
  • Service
  • Others

Clinical Trial Equipment & Ancillary Solutions Market, By Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Clinical Trial Equipment & Ancillary Solutions Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clinical Trial Equipment & Ancillary Solutions Market.

Available Customizations:

Global Clinical Trial Equipment & Ancillary Solutions Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clinical Trial Equipment & Ancillary Solutions Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Sourcing (Procurement, Rental), Supply/Logistics, Service, Others)
    • 5.2.2. By Phase (Phase I, Phase II, Phase III, Phase IV)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Clinical Trial Equipment & Ancillary Solutions Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Phase
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Phase
    • 6.3.2. Canada Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Phase
    • 6.3.3. Mexico Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Phase

7. Europe Clinical Trial Equipment & Ancillary Solutions Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Phase
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Phase
    • 7.3.2. France Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Phase
    • 7.3.3. United Kingdom Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Phase
    • 7.3.4. Italy Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Phase
    • 7.3.5. Spain Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Phase

8. Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Phase
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Phase
    • 8.3.2. India Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Phase
    • 8.3.3. Japan Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Phase
    • 8.3.4. South Korea Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Phase
    • 8.3.5. Australia Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Phase

9. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Phase
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Phase
    • 9.3.2. UAE Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Phase
    • 9.3.3. South Africa Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Phase

10. South America Clinical Trial Equipment & Ancillary Solutions Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Phase
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Phase
    • 10.3.2. Colombia Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Phase
    • 10.3.3. Argentina Clinical Trial Equipment & Ancillary Solutions Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Phase

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Clinical Trial Equipment & Ancillary Solutions Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Ancillare, LP
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Imperial Clinical Research Services Inc
  • 15.3. Woodley Equipment Company Ltd
  • 15.4. Thermo Fisher Scientific Inc
  • 15.5. PAREXEL International Corp
  • 15.6. Emsere
  • 15.7. Quipment SAS
  • 15.8. Marken Ltd.
  • 15.9. Myonex
  • 15.10. Yourway

16. Strategic Recommendations

17. About Us & Disclaimer